Navigation Links
Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
Date:3/7/2012

(March 7, 2012) HOBOKEN, NJ Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative or natural remedies are an easy, effective way to improve signs and symptoms linked to the menopausal transition, without side effects. Natural supplement Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was found to significantly improve signs and symptoms of menopause in a recent clinical trial published in Panminerva Medica.

The study was conducted at Pescara University and examined 70 perimenopausal women, aged 40-50 years. Perimenopause is the term used to describe the menopause transition years, typically the years before and after the final menstrual period. Participants were assigned to a placebo or test group. The test group was given 100 mg of Pycnogenol per day (50 mg taken twice daily), over a period of eight weeks. Participants' menopausal symptoms were evaluated by a scoring system, based on a total of 33 common signs and symptoms, using values ranging from zero (absent) to a maximum of four (very serious). Oxidative stress levels were evaluated by measuring capillary blood plasma free radicals from a drop of capillary blood from the finger tips.

The study found that:

  • Pycnogenol substantially improved perimenopausal signs and symptoms including hot flashes, night sweats, mood swings, irregular periods, loss of libido and vaginal dryness after eight weeks of treatment, as judged by patients' scores, showing a decrease from an average of 2.67/4 to 1.45/4
  • Pycnogenol effectively decreased the severity of hot flashes, decreased bloating and improved irregular heart beat and improved digestive problems
  • Menopausal symptoms categorized under "pain" improved significantly with the group taking Pycnogenol
  • Oxidative stress levels decreased significantly after Pycnogenol supplementation, improving quality of life and helping to control signs and symptoms of menopause

"As evidenced by this study, Pycnogenol may arguably represent a very effective basic, daily dietary supplement for menopausal women due to its extended range of health benefits, including cardiovascular benefits and Pycnogenol's proven ability to lower blood pressure," says Dr. Gianni Belcaro, the lead researcher from Pescara University, Italy.

Results showed that not only did Pycnogenol improve menopausal signs and symptoms, but also decreased elevated levels of oxidative stress, as shown by capillary blood tests. Pycnogenol's ability to manage heart health is of particular significance as menopausal women live at elevated risk for cardiovascular disease.

This study confirms previous findings that Pycnogenol effectively improves perimenopausal signs and symptoms. A previous study in Taiwan investigated 200 mg of Pycnogenol in 200 perimenopausal women over a period of half a year and identified an improvement in most signs and symptoms. This study demonstrated Pycnogenol's ability to improve signs and symptoms not only with a smaller dosage of Pycnogenol but also over a shorter period of time.


'/>"/>

Contact: Katherine Davis
kdavis@mww.com
312-981-8549
MWW Group
Source:Eurekalert

Related biology news :

1. Pycnogenol (French maritime pine bark extract) shown to improve visible signs of aging in new study
2. Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan
3. ComCam Selected by ePortation on New Maritime Domain Awareness Project
4. ComCam Selected by ePortation on New Maritime Domain Awareness Project
5. Stevens and TNO to collaborate on maritime security
6. National Center for Secure and Resilient Maritime Commerce releases annual report
7. New ways to chart our maritime past
8. NOAA, Spain announce cooperative arrangement to preserve maritime underwater heritage
9. Ultrasound shown to exert remote control of brain circuits
10. Dictyostelium cells shown to lay breadcrumb trail as first step in multicellular formation
11. Twin nanoparticle shown effective at targeting, killing breast cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Aug. 15 2017   ivWatch LLC , a medical device ... therapy, today announced receipt of its ISO 13485 Certification, the global ... International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection of ... "This is an important milestone ...
(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
Breaking Biology Technology: